Skip to main content
Jodie Dionne, MD, Infectious Disease, Birmingham, AL

Jodie Ann Dionne MD MSPH

HIV/AIDS Medicine, International Health, Travel & Tropical, STD Medicine


Associate Professor of Medicine and OB/GYN

Join to View Full Profile
  • 703 19th St S Bldg 206Birmingham, AL 35233

  • Phone+1 205-975-6530

Dr. Dionne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Dionne leads clinical trials and cohort studies in Infectious Diseases. Her research focuses on the treatment and prevention of syphilis, gonorrhea, and hepatitis B in women and pregnancy.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Infectious Disease, 2006 - 2009
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2006
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2002

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2009 - Present
  • AL State Medical License
    AL State Medical License 2013 - 2025
  • GA State Medical License
    GA State Medical License 2006 - 2009
  • NY State Medical License
    NY State Medical License 2003 - 2007
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Real-World Studies Boost Case for doxyPEP to Prevent Sexually Transmitted Diseases
    Real-World Studies Boost Case for doxyPEP to Prevent Sexually Transmitted DiseasesJanuary 8th, 2025
  • DoxyPEP Helps Reduce Sexually Transmitted Infections in California
    DoxyPEP Helps Reduce Sexually Transmitted Infections in CaliforniaJanuary 8th, 2025
  • Early Results of Doxy PEP Rollout Show Mixed Impact on STIs
    Early Results of Doxy PEP Rollout Show Mixed Impact on STIsJanuary 5th, 2025
  • Join now to see all

Grant Support

  • Syphilis in Pregnancy Study (SIPS): Molecular Diagnostics and Maternal and Infant Immune Response to InfectionUNIVERSITY OF ALABAMA AT BIRMINGHAM2023–2028
  • Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)UNIVERSITY OF ALABAMA AT BIRMINGHAM2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: